SRSF5 and pancreatic neoplasm: Mechanistically, we demonstrated that the CLK1-SRSF5 axis promoted pancreatic cancer proliferation via promoting Cyclin L2exon 6.3 skipping, and enhanced the ability of cell migration and invasion through inhibiting METTL14exon 10 skipping.